Raptiva Recall: Information and Warnings

Raptiva was a drug that treated moderate to severe psoriasis through subcutaneous injections once a week. The drug was first approved in 2003 but in 2008, the Food and Drug Administration (FDA) issued a black box warning notifying consumers of the risk of serious infections, including bacterial sepsis, viral meningitis and progressive multifocal leukoencephalopathy (PML). Then, in 2009, the FDA issued a Public Health Advisory notifying the public that there had been three confirmed and one possible case of PML by patients who had been taking Raptiva for a long period of time. All four of the consumers were taking Raptiva for more than three years and were not taking any other drugs that suppressed the immune system. Three of the patients with PML died. In 2009, Genentech, the company that manufactures Raptiva, suspended sales of the drug in the United States.

Raptiva and Progressive Multifocal Leukoencephalopathy (PML): PML is a viral infection of the brain and is often fatal. The disease is caused by the JC virus, which is dormant for most people who carry it and only causes disease when the immune system is severely weakened. Symptoms of PML include confusion, weakness, paralysis, vision loss and cognitive deterioration. In about 10% of the PML cases, patients survived longer than 12 months but the result is usually fatal. There are currently no treatments or cures for PML.

Raptiva and Bacterial Sepsis: Sepsis occurs when there is an inflammation in the body because of a known or suspected infection. The response to sepsis may be in the blood, urine, lungs, or other tissue. Sepsis is usually treated in the intensive care unit with intravenous fluids and antibiotics. The symptoms of sepsis include an acute inflammation to the body and may be associated with a fever and a high white blood cell count.

Raptiva and Viral Meningitis: Viral meningitis is an inflammation of the membranes around the spinal cord or the brain. Viral meningitis is actually less severe than bacterial meningitis and may clear up without specific treatment. Some symptoms of viral meningitis include fever, headache, nausea and vomiting. Patients with healthy immune systems generally recover on their own after a couple of weeks.

If you have been injured by Raptiva by developing PML, meningitis, encephalitis, cancer, lymphomas, Hodgkin’s Disease or any serious infection after taking Raptiva, or a very severe case of psoriasis after cessation of Raptiva usage, then you may be able to obtain compensation from the manufacturers for your damages. However, you must act on this immediately or else you may risk losing your ability to file a lawsuit under your state’s statute of limitations, which dictates how long you may have to file a claim.

Check out the following articles for more information about Raptiva, filing a Raptiva lawsuit and finding a Raptiva attorney.